NewsRoom Articles - Page 1080 of 1389

TuesdayMar 13, 2018 4:30 pm

Acer Therapeutics, Inc. (NASDAQ: ACER) Starts Presentation at 30th Annual ROTH Conference

Acer Therapeutics (NASDAQ: ACER) is a pharmaceutical company focused on the acquisition, development and commercialization of therapies for patients with serious rare and ultra-rare diseases with critical unmet medical need. The company’s late-stage clinical pipeline includes EDSIVO™ for vascular Ehlers-Danlos syndrome (vEDS) and ACER-001 for urea cycle disorders (UCD) and Maple Syrup Urine Disease (MSUD). Currently, there are no FDA-approved drugs for vEDS and MSUD and limited options for UCD, which together impact more than 4,000 patients in the United States. Acer’s product candidates have clinical proof-of-concept and mechanistic differentiation, and Acer intends to seek approval for them in the…

TuesdayMar 13, 2018 4:30 pm

Delcath Systems, Inc. (DCTH) Starts Presentation at 30th Annual ROTH Conference

Delcath Systems (OTC: DCTH) is a specialty pharmaceutical and medical device company focused on the treatment of primary and metastatic liver cancers. The company’s proprietary product, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS), is designed to administer high dose chemotherapy to the liver, while controlling the systemic exposure to those agents. The company has commenced a global phase 3 FOCUS clinical trial for patients with hepatic dominant ocular melanoma and plan to initiate a registration trial for intrahepatic cholangiocarcinoma (“ICC”) in the fall of 2017. The company’s Delcath Hepatic CHEMOSAT® Delivery System for Melphalan…

TuesdayMar 13, 2018 4:30 pm

Transcat, Inc. (NASDAQ: TRNS) Starts Presentation at 30th Annual ROTH Conference

Transcat (NASDAQ: TRNS) provides accredited calibration, repair, inspection and laboratory instrument services, with a focus on offering best-in-class services and products to highly regulated industries such as life science, aerospace and defense, pharmaceutical, medical device manufacturing and biotechnology. The company’s strategy is to leverage the complementary nature of its two operating segments, its comprehensive service capabilities, strong brand, enhanced e-commerce capabilities and leading distribution platform to drive organic sales growth. Transcat will also look to expand its addressable calibration market through acquisitions and capability investments to further realize the inherent leverage of its business model. For more information, visit the…

TuesdayMar 13, 2018 4:00 pm

Assure Holdings Corp. (ARHH) Starts Presentation at 30th Annual ROTH Conference

Assure Holdings (OTCQB: ARHH) works with neurosurgeons and orthopedic spine surgeons to provide a turnkey suite of services that support intraoperative neuromonitoring activities during invasive surgeries. Assure employs its own staff of technologists and uses its own state-of-the-art monitoring equipment, handles intraoperative neuromonitoring scheduling and setup, and bills for all technical services provided. Although the company focuses primarily on supporting spinal and vascular surgeries, plans are in place to support other classes of medicine that rely on the standard of care that intraoperative neuromonitoring provides. For more information, visit the company’s website at www.assureneuromonitoring.com. About NetworkNewsWire NetworkNewsWire (NNW) is a…

TuesdayMar 13, 2018 4:00 pm

TRACON Pharmaceuticals, Inc. (NASDAQ: TCON) Starts Presentation at 30th Annual ROTH Conference

TRACON (NASDAQ: TCON) develops targeted therapies for cancer, ophthalmic and fibrotic diseases. The company’s clinical-stage pipeline includes: TRC105, an endoglin antibody that is being developed for the treatment of multiple cancers; DE-122, the ophthalmic formulation of TRC105 that is being developed in wet AMD through a collaboration with Santen Pharmaceutical Company Ltd.; TRC102, a small molecule being developed for the treatment of lung cancer and glioblastoma; and TRC253, a small molecule being developed for the treatment of prostate cancer. For more information, visit the company’s website at www.traconpharma.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company…

TuesdayMar 13, 2018 4:00 pm

ID Systems, Inc. (NASDAQ: IDSY) Starts Presentation at 30th Annual ROTH Conference

ID Systems (NASDAQ: IDSY) is a global provider of wireless M2M solutions for securing, controlling, tracking, and managing high-value enterprise assets, including rental cars, industrial vehicles, trailers, containers and cargo. ID Systems’ patented technologies address the needs of organizations to monitor and analyze their assets to increase efficiency and productivity, reduce costs, and improve profitability. The company is headquartered in Woodcliff Lake, New Jersey, with subsidiaries in Texas, Germany, and the United Kingdom. For more information, visit the company’s website at www.id-systems.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a…

TuesdayMar 13, 2018 4:00 pm

Acushnet Holdings Corp. (NYSE: GOLF) Starts Presentation at 30th Annual ROTH Conference

Acushnet Holdings (NYSE: GOLF) is engaged in the design, development, manufacture and distribution of quality, performance-driven golf products. The company’s mission since 1932 has remained consistent, striving to be the performance and quality leader in every golf product category in which it competes. Today, the company is the steward of two of the most revered brands in golf — Titleist, a golf performance equipment brand, and FootJoy, a golf performance wearables brands. For more information, visit the company’s website at www.acushnetholdingscorp.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network…

TuesdayMar 13, 2018 4:00 pm

Highpower International, Inc. (NASDAQ: HPJ) Starts Presentation at 30th Annual ROTH Conference

Highpower International (NASDAQ: HPJ), through its subsidiaries, is engaged in the manufacturing and marketing of nickel metal hydride rechargeable batteries (Ni-MH) and lithium batteries for both consumer and industrial applications. With over 3,000 employees and advanced manufacturing facilities located in Shenzhen and Huizhou of China, Highpower is committed to clean technology, not only in the products it makes, but also in the processes of production. The majority of Highpower International’s products are distributed to worldwide markets mainly in the United States, Europe, China and Southeast Asia. For more information, visit the company’s website at www.highpowertech.com. About NetworkNewsWire NetworkNewsWire (NNW) is…

TuesdayMar 13, 2018 4:00 pm

ORBCOMM, Inc. (NASDAQ: ORBC) Starts Presentation at 30th Annual ROTH Conference

ORBCOMM (NASDAQ: ORBC) is a global leader and innovator in the industrial Internet of Things, providing solutions that connect businesses to their assets to deliver increased visibility and operational efficiency. The company offers a broad set of asset monitoring and control solutions, including seamless satellite and cellular connectivity, unique hardware and powerful applications, all backed by end-to-end customer support, from installation to deployment to customer care. ORBCOMM has a diverse customer base including premier OEMs, solutions customers and channel partners spanning transportation, supply chain, warehousing and inventory, heavy equipment, maritime, natural resources, and government. For more information, visit the company’s…

TuesdayMar 13, 2018 4:00 pm

Benitec Biopharma Ltd (NASDAQ: BNTC) Starts Presentation at 30th Annual ROTH Conference

Benitec Biopharma (NASDAQ: BNTC) is a biotechnology company developing innovative therapeutics for chronic and life-threatening human diseases based on its patented gene-silencing technology, DNA-directed RNA interference or 'expressed RNAi' (“ddRNAi”). Based in Sydney, Australia with laboratories in Hayward, California and collaborators and licensees around the world, the company is developing ddRNAi-based therapeutics for conditions including hepatitis B, wet age-related macular degeneration and OPMD. Benitec has also licensed ddRNAi to other biopharmaceutical companies for applications including HIV/AIDS, Huntington's Disease, chronic neuropathic pain and retinitis pigmentosa. For more information, visit the company’s website at www.benitec.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Acer Therapeutics, Inc. (NASDAQ: ACER) Starts Presentation at 30th Annual ROTH Conference

Delcath Systems, Inc. (DCTH) Starts Presentation at 30th Annual ROTH Conference

Transcat, Inc. (NASDAQ: TRNS) Starts Presentation at 30th Annual ROTH Conference

Assure Holdings Corp. (ARHH) Starts Presentation at 30th Annual ROTH Conference

TRACON Pharmaceuticals, Inc. (NASDAQ: TCON) Starts Presentation at 30th Annual ROTH Conference

ID Systems, Inc. (NASDAQ: IDSY) Starts Presentation at 30th Annual ROTH Conference

Acushnet Holdings Corp. (NYSE: GOLF) Starts Presentation at 30th Annual ROTH Conference

Highpower International, Inc. (NASDAQ: HPJ) Starts Presentation at 30th Annual ROTH Conference

ORBCOMM, Inc. (NASDAQ: ORBC) Starts Presentation at 30th Annual ROTH Conference

Benitec Biopharma Ltd (NASDAQ: BNTC) Starts Presentation at 30th Annual ROTH Conference

NetworkNewsWire Currently Accepts

NetworkNewsWire

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsWire Currently Accepts

Company Search

Site Search